✦ LIBER ✦

Laboratory Monitoring of Heparin and the Combination of Heparin and the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3) in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA)

✍ Scribed by Ralf Zahn; Hannelore Haubelt; Sabine Bechtloff; Steffen Schneider; Birgit Frilling; Jörg Rustige; Parvaneh Marsalek; Karlheinz Seidl; Jochen Senges; Peter Hellstern

Book ID: 105773238
Publisher: Urban and Vogel
Year: 2003
Tongue: German
Weight: 356 KB
Volume: 28
Category: Article
ISSN: 0340-9937
DOI: 10.1007/s00059-003-2349-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Standard Versus Low-Dose Weight-Adjusted

Standard Versus Low-Dose Weight-Adjusted Heparin in Patients Treated With the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3 Fab) During Percutaneous Coronary Revascularization

✍ A.Michael Lincoff; MD; James E. Tcheng; MD; Robert M. Califf; MD; Theodore Bass; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Evidence for Prevention of Death and Myo

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization

✍ A.Michael Lincoff; Robert M. Califf; Keaven M. Anderson; Harlan F. Weisman; Fran 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 233 KB

711-3-A Multicenter, Randomized, Double-

711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary Revascularization

✍ A. Michael Lincoff; James E. Tcheng; Theodore A. Bass; Jeffrey J. Popma; Paul S. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 237 KB

The effect of bivalirudin in combination

The effect of bivalirudin in combination with ticlopidine on laboratory coagulation parameters and the incidence of clinically significant bleeding in patients undergoing percutaneous transluminal coronary angioplasty (PTCA) and stenting

✍ M.J. Abernethy; P.E. Aylward; J.I. Weitz; C.M. Frampton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Efficacy and safety of enoxaparin compar

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial

✍ Harvey D. White; Neal S. Kleiman; Kenneth W. Mahaffey; Yuliya Lokhnygina; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 333 KB